PSMA Clinical Trials in Essen
2 recruitingEssen, Germany
Showing 1–2 of 2 trials
Recruiting
Phase 1Phase 2
A Phase Ib/II Open-label Study of AMO959 With Lutetium (177Lu) Vipivotide Tetraxetan (AAA617) in Combination With ARPI in Adult Participants With PSMA-positive mCRPC
PSMA-positive Metastatic Castration Resistant Prostate Cancer (mCRPC) With Prior Exposure to One Prior ARPI Who Are Candidates for Taxane-based Chemotherapy
Novartis Pharmaceuticals123 enrolled11 locationsNCT07226986
Recruiting
PROMISE PET Registry on PSMA-PET and Outcome in Prostate Cancer
Prostate CancerSurvivorshipPET/CT+1 more
University Hospital, Essen10,000 enrolled1 locationNCT06320223